6533b837fe1ef96bd12a22d2
RESEARCH PRODUCT
Anti-IL1 in patients with low penetrance mutations for autoinflammatory diseases: tuscany and sicilian case series from paediatric to adult age
Maria Cristina MaggioLuca CantariniGiovanni CorselloUmberto CorporaRolando Cimazsubject
Settore MED/38 - Pediatria Generale E SpecialisticaAutoinflammatory syndromes anti-IL-1 IL-1description
Patients with low penetrance mutations for Autoinflammatory syndromes (AID) can have severe clinical manifestations, which require to be treated with biological drugs anti-IL-1. Objectives: To evaluate the response of AID to treatment with the recombinant human IL-1 receptor antagonist anakinra or with the anti-IL-1b.
year | journal | country | edition | language |
---|---|---|---|---|
2017-01-01 |